Mind Medicine Inc (NAS:MNMD)
$ 8.19 -0.78 (-8.7%) Market Cap: 600.59 Mil Enterprise Value: 438.17 Mil PE Ratio: 0 PB Ratio: 2.93 GF Score: 41/100

Q2 2021 Mind Medicine (MindMed) Inc Earnings Call Transcript

Aug 16, 2021 / 08:00PM GMT
Collin Gage;MindMed;Inc.;VP of Corporate Development;Robert Barrow;
Mind Medicine;Mind Medicine

()-

Good afternoon, and welcome to MindMed's Q2 2021 Earnings Call. This is Collin Gage, VP of Corporate Development from MindMed. I will be coordinating today's conference.

I'd like to draw your attention to the fact that this conference call will contain forward-looking information, which may include, but is not limited to statements of (inaudible), business plans and strategies for MindMed. Forward-looking statements are made as of today's date and involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of MindMed to be materially different than the forward-looking statements. We draw your attention to the full disclaimer contained in our filings on SEDAR and EDGAR.

Leading the call today will be Interim MindMed CEO, Rob Barrow. Please e-mail any questions you may have to [email protected]. Rob, you may begin the call.

- (

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot